In today’s global market, the pharmaceutical industry plays a crucial role in ensuring the health and well-being of people across the globe.
Due to factors like aging population, increase in chronic diseases and diabetes, advancements in technology and breakthroughs in drug discovery, the pharmaceuticals market worldwide is projected to grow by 5.39% from 2023-2027, resulting in a market volume of $1435 billion by 2027.
The market attractiveness makes it competitive and with so many companies vying for the top spot, the reputation and perceptions of these companies can become a decisive factor, when it comes to patients choosing their providers, employees – their employers and investors their prospects for investment.
As a part of Caliber’s recent Global Pharma reputation study, we have surveyed thousands of people from various stakeholder groups in seven countries: Brazil, China, France, Germany, Japan, the UK, and the US to find out which Pharmaceutical companies do they Trust & Like the most.
This report is based on the insights gathered in 2022 and is based on interviews with more than 17,600 people. The companies included in this report were selected as market leaders in the pharmaceutical sector and are representative of the industry in their respective geographies.
Our corporate reputation research model explains the journey from stakeholder interaction to business impact – comprising elements such as awareness, rational perceptions, trust and supportive behavior.
The Trust & Like Score is the ultimate metric that sums up the results of KPI’s which measure factors like perceived offering, innovation, integrity, relevance and many more.
In simple terms, the Trust & Like Score represents the overall brand reputation health.